Lymphoma Clinical Trials

Showing 2241-2260 of 2,926 trials

Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia

NCT01944943

The purpose of this study is to determine the efficacy of Vismodegib drug in treatment of patients with relapsed or refractory B-cell lymphoma or chronic lymphocytic leukemia (CLL).

Diffuse Large B-cell LymphomaIndolent Non-hodgkin LymphomaPrimary Central Nervous System Lymphoma+1 more

The Lymphoma Academic Research Organisation31 participantsStarted Feb 2013

Créteil, France • Dijon, France • Lille, France +7 more locations

COMPLETEDPhase 2

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

NCT00848926

This is a single-arm, open-label, multicenter, pivotal clinical trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) as a single agent in patients with relapsed or refractory Hodgkin lymphoma.

Disease, Hodgkin

Seagen Inc.102 participantsStarted Feb 2009

Birmingham, Alabama, United States • Duarte, California, United States • Los Angeles, California, United States +24 more locations

Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic Leukemia

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

Related Searches

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma

Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL

Treatment of Aggressive Localized Lymphoma

Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy

CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL

Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation

Phase I Study of CS-7017 and Bexarotene

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT

Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients

Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Mediastinal Grey Zone Lymphoma From the LYSA

Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma

Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment